Hence, in our HF models, empagliflozin might alleviate isoproterenol-induced cardiac dysfunction by attenuating SERCA dysfunction or calcium leakage due to phosphorylated ryanodine receptor in HF through reducing oxidative stress or CaMKII activity [3, 40, 60]. The gene discussed is CAMK2G; the disease is hydrops fetalis.